Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

Antibiotic-resistant Bacterial Infection of Hepatic Patients

NCT03855709 ·Status: UNKNOWN

Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital

NCT06173440 ·Status: RECRUITING

Surveillance Study of Candiduria in Hospitalized Patients

NCT03910764 ·Status: COMPLETED

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

NCT04131569 ·Status: UNKNOWN

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

NCT03967301 ·Status: UNKNOWN ·Phase: NA

Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases

NCT02127450 ·Status: COMPLETED

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

NCT02852902 ·Status: COMPLETED

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives

NCT03250104 ·Status: COMPLETED

The Epidemiology of Infection With Vancomycin-Resistant Enterococci

NCT00018434 ·Status: COMPLETED

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

NCT02803710 ·Status: UNKNOWN

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

NCT06252428 ·Status: COMPLETED

Study of Antibiotic Utilization Measures and Control of ESBLs in China

NCT00488813 ·Status: COMPLETED ·Phase: PHASE4

Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)

NCT06095076 ·Status: UNKNOWN

Italian National Study on the Critically Ill Liver Transplant Patient With an Infection

NCT03363646 ·Status: UNKNOWN

Community-associated Highly-Resistant Enterobacterales

NCT03924934 ·Status: COMPLETED

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

NCT03350178 ·Status: TERMINATED ·Phase: PHASE2

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

NCT06782880 ·Status: RECRUITING ·Phase: NA

Gut Microbiota Pilot Study

NCT03897023 ·Status: UNKNOWN

Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization

NCT02839980 ·Status: COMPLETED

Clinical and Biological Impact of Gut Microbiota in Adult Patients With Bacteremia During the COVID-19 Pandemic

NCT07183722 ·Status: ACTIVE_NOT_RECRUITING

Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection

NCT07130799 ·Status: RECRUITING

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

NCT01764490 ·Status: COMPLETED

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

NCT02364284 ·Status: COMPLETED

BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU

NCT03147807 ·Status: COMPLETED ·Phase: NA

Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections

NCT05258851 ·Status: TERMINATED ·Phase: PHASE3